NCT01344525

Brief Summary

Obese individuals that undergo major intervention such as a low-calorie formula diet program or bariatric surgery with the result of substantial weight loss (\> 10%) are included and followed-up for at least 3 years. Weight changes and excess weight loss as well as measures of quality of life are monitored. In addition, biomaterials will be collected from these individuals every 6 months for measurement of parameters related to obesity-associated gastrointestinal (GI) impairments such as change in GI hormone levels, change in GI microbiota, or enhanced bacterial translocation. Moreover, micronutrient and metabolomics analysis will be performed. This project allows comparison of non-surgical and surgical intervention and enables to asses the anticipated relationship between obesity and the GI tract in humans in the future.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
480

participants targeted

Target at P75+ for not_applicable obesity

Timeline
37mo left

Started May 2009

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
May 2009May 2029

Study Start

First participant enrolled

May 1, 2009

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

April 27, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 29, 2011

Completed
18 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2029

Last Updated

October 26, 2018

Status Verified

October 1, 2018

Enrollment Period

20 years

First QC Date

April 27, 2011

Last Update Submit

October 25, 2018

Conditions

Keywords

obesity therapymetabolic syndromegastrointestinal tractmicrobiotametabolomicsmicronutrientsoutcomesustainability

Outcome Measures

Primary Outcomes (1)

  • Body weight loss

    Every 6 months for a period of 3 years

Secondary Outcomes (8)

  • Quality of life

    Every 6 months for a period of 3 years

  • Physical examination

    Every 6 months for a period of 3 years

  • Laboratory analysis

    Every 6 months for a period of 3 years

  • Vitamins/micronutrients

    Every 3-6 months for a period of maximal 3 years

  • Metabolomics, and Microflora analysis

    Every 3-6 months for a period of maximal 3 years

  • +3 more secondary outcomes

Study Arms (4)

Control group

NO INTERVENTION

Nutritional counselings every 6 months, no further intervention

"low-calorie-diet (LCD)"-based lifestyle intervention

EXPERIMENTAL

12 months multidisciplinary weight loss program including three months low-calorie formula diet (800 kcal) (OPTIFAST®52 program)

Procedure: Multidisciplinary lifstyle intervention

Laparoscopic gastric sleeve intervention

EXPERIMENTAL
Procedure: Laparoscopic gastric sleeve

Conventional bariatric surgery

EXPERIMENTAL

Gastric Banding and Gastric Bypass

Procedure: Gastric BandingProcedure: Roux-en-Y Bypass

Interventions

Laparoscopic gastric sleeve

Laparoscopic gastric sleeve intervention

Gastric Banding

Conventional bariatric surgery

Multidisciplinary lifstyle intervention (OPTIFAST®52-program)

"low-calorie-diet (LCD)"-based lifestyle intervention

Roux-en-Y Bypass

Conventional bariatric surgery

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obesity defined as BMI \> 30 kg/m2
  • Obesity treatment (multidisciplinary life style intervention with LCD or bariatric surgery) resulting in an estimated body weight loss of \>10% of the initial body weight within 6 month

You may not qualify if:

  • Body weight loss after intervention \< 10%
  • Follow-up period \< 1 year or number of consultations within 3 years \< 3

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Heidelberg

Heidelberg, 69120, Germany

RECRUITING

University of Hohenheim

Stuttgart, 70599, Germany

RECRUITING

University of Tübingen

Tübingen, 72076, Germany

RECRUITING

Related Publications (4)

  • Damms-Machado A, Louis S, Schnitzer A, Volynets V, Rings A, Basrai M, Bischoff SC. Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. Am J Clin Nutr. 2017 Jan;105(1):127-135. doi: 10.3945/ajcn.116.131110. Epub 2016 Nov 9.

  • Damms-Machado A, Mitra S, Schollenberger AE, Kramer KM, Meile T, Konigsrainer A, Huson DH, Bischoff SC. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015;2015:806248. doi: 10.1155/2015/806248. Epub 2015 Feb 1.

  • Damms-Machado A, Weser G, Bischoff SC. Micronutrient deficiency in obese subjects undergoing low calorie diet. Nutr J. 2012 Jun 1;11:34. doi: 10.1186/1475-2891-11-34.

  • Damms-Machado A, Friedrich A, Kramer KM, Stingel K, Meile T, Kuper MA, Konigsrainer A, Bischoff SC. Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2012 Jun;22(6):881-9. doi: 10.1007/s11695-012-0609-0.

MeSH Terms

Conditions

ObesityWeight LossMetabolic Syndrome

Interventions

Anastomosis, Roux-en-Y

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight ChangesInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Intervention Hierarchy (Ancestors)

Anastomosis, SurgicalSurgical Procedures, OperativeDigestive System Surgical Procedures

Study Officials

  • Stephan C. Bischoff, Prof. Dr.

    University of Hohenheim, Institute of Nutritional Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Antje Damms-Machado, Dipl. troph.

CONTACT

Katrin Stingel, Dipl. troph.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2011

First Posted

April 29, 2011

Study Start

May 1, 2009

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

May 1, 2029

Last Updated

October 26, 2018

Record last verified: 2018-10

Locations